tradingkey.logo

Standard BioTools Inc

LAB
1.260USD
+0.020+1.61%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
483.35MMarktkapitalisierung
VerlustKGV TTM

Standard BioTools Inc

1.260
+0.020+1.61%

mehr Informationen über Standard BioTools Inc Unternehmen

Standard BioTools Inc. develops, manufactures and sells a diversified range of instrumentation, consumables, and services that help scientists and biomedical researchers. The Company's segments include Proteomics and Genomics. The Proteomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of genes (DNA, RNA) and their functions. The Company works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy. It offers a diverse range of instrumentation, consumables, and services that generate data across early discovery, translational and clinical research.

Standard BioTools Inc Informationen

BörsenkürzelLAB
Name des UnternehmensStandard BioTools Inc
IPO-datumFeb 10, 2011
CEOEgholm (Michael)
Anzahl der mitarbeiter818
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 10
Addresse2 Tower Place
StadtSOUTH SAN FRANCISCO
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl94080
Telefon16502666000
Websitehttps://www.standardbio.com/
BörsenkürzelLAB
IPO-datumFeb 10, 2011
CEOEgholm (Michael)

Führungskräfte von Standard BioTools Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
157.01K
+94592.00%
Mr. Sean Mackay
Mr. Sean Mackay
Chief Business Officer
Chief Business Officer
65.77K
-19661.00%
Dr. Franklin R. (Frank) Witney, Ph.D.
Dr. Franklin R. (Frank) Witney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Michael Egholm, Ph.D.
Dr. Michael Egholm, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Hanjoon Alex Kim
Mr. Hanjoon Alex Kim
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Thomas (Tom) Carey
Mr. Thomas (Tom) Carey
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Kathy Hibbs
Ms. Kathy Hibbs
Independent Director
Independent Director
--
--
Mr. Troy Cox
Mr. Troy Cox
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
157.01K
+94592.00%
Mr. Sean Mackay
Mr. Sean Mackay
Chief Business Officer
Chief Business Officer
65.77K
-19661.00%
Dr. Franklin R. (Frank) Witney, Ph.D.
Dr. Franklin R. (Frank) Witney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Michael Egholm, Ph.D.
Dr. Michael Egholm, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Hanjoon Alex Kim
Mr. Hanjoon Alex Kim
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Consumables
8.71M
44.52%
Services and other revenue
5.75M
29.42%
Instruments
5.09M
26.06%
Nach RegionUSD
Name
Umsatz
Anteil
Americas
7.84M
40.11%
Europe & Middle East & Africa (EMEA)
7.25M
37.06%
Asia-Pacific
4.46M
22.84%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Consumables
8.71M
44.52%
Services and other revenue
5.75M
29.42%
Instruments
5.09M
26.06%

Aktionärsstatistik

Aktualisiert: Sat, Nov 15
Aktualisiert: Sat, Nov 15
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Casdin Capital, LLC
23.09%
Viking Global Investors LP
15.25%
BlackRock Institutional Trust Company, N.A.
5.67%
MAK Capital One, LLC
5.19%
The Vanguard Group, Inc.
4.48%
Andere
46.31%
Aktionäre
Aktionäre
Anteil
Casdin Capital, LLC
23.09%
Viking Global Investors LP
15.25%
BlackRock Institutional Trust Company, N.A.
5.67%
MAK Capital One, LLC
5.19%
The Vanguard Group, Inc.
4.48%
Andere
46.31%
Aktionärstypen
Aktionäre
Anteil
Hedge Fund
33.44%
Investment Advisor/Hedge Fund
27.49%
Investment Advisor
14.80%
Individual Investor
2.53%
Research Firm
0.66%
Venture Capital
0.57%
Bank and Trust
0.24%
Pension Fund
0.11%
Insurance Company
0.02%
Andere
20.13%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
332
297.38M
77.33%
-29.00M
2025Q3
324
277.96M
72.29%
-27.47M
2025Q2
337
283.64M
74.68%
-28.24M
2025Q1
336
286.88M
75.60%
-24.96M
2024Q4
322
279.84M
75.18%
-22.14M
2024Q3
315
282.67M
78.53%
-14.93M
2024Q2
303
268.49M
74.97%
-14.97M
2024Q1
306
263.03M
71.99%
+131.65M
2023Q4
264
54.09M
66.99%
-14.10M
2023Q3
265
53.37M
67.31%
-13.39M
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Casdin Capital, LLC
88.78M
23.09%
+350.00K
+0.40%
Dec 04, 2025
Viking Global Investors LP
58.65M
15.25%
--
--
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
21.81M
5.67%
+20.05K
+0.09%
Sep 30, 2025
MAK Capital One, LLC
15.93M
4.14%
+10.33M
+184.63%
Sep 30, 2025
The Vanguard Group, Inc.
17.19M
4.47%
+263.85K
+1.56%
Sep 30, 2025
Long Focus Capital Management LLC
11.36M
2.95%
+1.29M
+12.84%
Sep 30, 2025
Geode Capital Management, L.L.C.
7.47M
1.94%
+27.78K
+0.37%
Sep 30, 2025
State Street Investment Management (US)
6.40M
1.66%
+101.35K
+1.61%
Sep 30, 2025
Hollow Brook Wealth Management, LLC
5.78M
1.5%
+165.43K
+2.95%
Sep 30, 2025
Morgan Stanley Investment Management Inc. (US)
5.64M
1.47%
+285.46K
+5.33%
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Invesco NASDAQ Future Gen 200 ETF
0.51%
ARK Genomic Revolution ETF
0.33%
iShares Micro-Cap ETF
0.07%
iShares Biotechnology ETF
0.04%
iShares Russell 2000 Value ETF
0.03%
ProShares Hedge Replication ETF
0.02%
ProShares UltraPro Russell2000
0.02%
iShares Russell 2000 ETF
0.01%
Global X Russell 2000 ETF
0.01%
Fidelity MSCI Health Care Index ETF
0.01%
Mehr Anzeigen
Invesco NASDAQ Future Gen 200 ETF
Anteil0.51%
ARK Genomic Revolution ETF
Anteil0.33%
iShares Micro-Cap ETF
Anteil0.07%
iShares Biotechnology ETF
Anteil0.04%
iShares Russell 2000 Value ETF
Anteil0.03%
ProShares Hedge Replication ETF
Anteil0.02%
ProShares UltraPro Russell2000
Anteil0.02%
iShares Russell 2000 ETF
Anteil0.01%
Global X Russell 2000 ETF
Anteil0.01%
Fidelity MSCI Health Care Index ETF
Anteil0.01%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI